| The Global Epidemic of the Metabolic Syndrome |
257 |
| Chronotherapy for Hypertension |
28 |
| Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure |
28 |
| Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension |
18 |
| New Approaches in Hypertension Management: a Review of Current and Developing Technologies and Their Potential Impact on Hypertension Care |
17 |
| The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia |
15 |
| Hypertension as a Metabolic Disorder and the Novel Role of the Gut |
14 |
| ACE Inhibitor-Induced Angioedema: a Review |
14 |
| Effectiveness of mHealth Interventions in Improving Medication Adherence Among People with Hypertension: a Systematic Review |
13 |
| Adaptive Immunity in Hypertension |
13 |
| Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders |
13 |
| Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis |
13 |
| The Role of Interleukin-10 in the Pathophysiology of Preeclampsia |
12 |
| Revisiting the Brain Renin-Angiotensin SystemFocus on Novel Therapies |
11 |
| Dimerization of AT(2) and Mas Receptors in Control of Blood Pressure |
10 |
| Enhancing Mitochondrial Health to Treat Hypertension |
10 |
| Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension |
9 |
| Integrative Physiological Aspects of Brain RAS in Hypertension |
9 |
| Weight Loss Medications in the Treatment of Obesity and Hypertension |
9 |
| Endovascular Baroreflex Amplification for Resistant Hypertension |
8 |
| Arterial Stiffness in Hypertension: an Update |
8 |
| Vasopressin, Central Autonomic Control and Blood Pressure Regulation |
8 |
| Inflammation in Salt-Sensitive Hypertension and Renal Damage |
8 |
| Microvascular Endothelial Dysfunction in Patients with Obesity |
8 |
| Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health |
8 |
| Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension |
7 |
| Sympathetic Nervous System, Sleep, and Hypertension |
7 |
| Alcohol and Hypertension-New Insights and Lingering Controversies |
7 |
| Patho-immune Mechanisms of Hypertension in HIV: a Systematic and Thematic Review |
7 |
| The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia? |
7 |
| The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis |
7 |
| Automated Office-Based Blood Pressure Measurement: an Overview and Guidance for Implementation in Primary Care |
7 |
| Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis |
7 |
| Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension |
7 |
| Cerebral Haemodynamics: Effects of Systemic Arterial Pulsatile Function and Hypertension |
7 |
| Control of Energy Expenditure by AgRP Neurons of the Arcuate Nucleus: Neurocircuitry, Signaling Pathways, and Angiotensin |
7 |
| Implications of the 2017 AAP Clinical Practice Guidelines for Management of Hypertension in Children and Adolescents: a Review |
7 |
| Sleep Duration and Blood Pressure: Recent Advances and Future Directions |
7 |
| Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT) |
7 |
| Hypertension in Developing Countries: A Major Challenge for the Future |
7 |
| Preeclampsia and Related Cardiovascular Risk: Common Genetic Background |
7 |
| Innate and Innate-Like Immune System in Hypertension and Vascular Injury |
7 |
| The Complement Alternative Pathway and Preeclampsia |
6 |
| Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review |
6 |
| Pheochromocytomas and Hypertension |
6 |
| Skin Sodium and Hypertension: a Paradigm Shift? |
6 |
| Atherosclerotic Renal Artery Stenosis: Should we Intervene Earlier? |
6 |
| Environmental Toxicant Exposure and Hypertensive Disorders of Pregnancy: Recent Findings |
6 |
| Role of TRPC6 in Progression of Diabetic Kidney Disease |
6 |
| An Overview of Metabolic Phenotyping in Blood Pressure Research |
6 |
